213 related articles for article (PubMed ID: 28213781)
1. Swedish prospective multicenter trial on the accuracy and clinical relevance of sentinel lymph node biopsy before neoadjuvant systemic therapy in breast cancer.
Zetterlund L; Celebioglu F; Axelsson R; de Boniface J; Frisell J
Breast Cancer Res Treat; 2017 May; 163(1):93-101. PubMed ID: 28213781
[TBL] [Abstract][Full Text] [Related]
2. Oncologic Outcomes for Different Axillary Staging Techniques in Patients with Nodal-Positive Breast Cancer Undergoing Neoadjuvant Systematic Treatment: A Cancer Registry Study.
Pfob A; Kokh DB; Surovtsova I; Riedel F; Morakis P; Heil J
Ann Surg Oncol; 2024 Jul; 31(7):4381-4392. PubMed ID: 38710911
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of sentinel node biopsy according to MRI response in an association with the subtypes in cN1-3 breast cancer after neoadjuvant systemic therapy, multicenter cohort study.
Bae SJ; Chun JW; Lee SB; Ryu JM; Nam SJ; Jeong J; Park HS; Ahn SG
Breast Cancer Res; 2024 Apr; 26(1):66. PubMed ID: 38632652
[TBL] [Abstract][Full Text] [Related]
4. Personalizing Locoregional Therapy in Patients With Breast Cancer in 2024: Tailoring Axillary Surgery, Escalating Lymphatic Surgery, and Implementing Evidence-Based Hypofractionated Radiotherapy.
Weber WP; Hanson SE; Wong DE; Heidinger M; Montagna G; Cafferty FH; Kirby AM; Coles CE
Am Soc Clin Oncol Educ Book; 2024 Jun; 44(3):e438776. PubMed ID: 38815195
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Male Breast Cancer and the Application of Sentinel Lymph Node Biopsy: A Multicenter Retrospective Study.
Shang Q; Feng K; Wei Y; Wang K; Yang C; Zhao S; Liu J; Meng X; Li Y; Du C; Wang J; Qiao G; Li J; Wang X; Wang X
Oncologist; 2023 Dec; 28(12):e1170-e1178. PubMed ID: 37399228
[TBL] [Abstract][Full Text] [Related]
6. Surgical Management of the Axilla in HR+/HER2- Breast Cancer in the Z1071 Era: A Propensity Score-Matched Analysis of the National Cancer Database.
Barker VR; Naffouje SA; Mallory MA; Hoover SA; Laronga C
Ann Surg Oncol; 2023 Dec; 30(13):8371-8380. PubMed ID: 37610487
[TBL] [Abstract][Full Text] [Related]
7. Absence of post-treatment changes in sentinel lymph nodes does not translate into increased regional recurrence rate in initially node-positive breast cancer patients.
Pislar N; Gasljevic G; Ratosa I; Kovac A; Zgajnar J; Perhavec A
Breast Cancer Res Treat; 2023 Dec; 202(3):443-450. PubMed ID: 37679645
[TBL] [Abstract][Full Text] [Related]
8. Sentinel lymph node biopsy after nipple-sparing mastectomy in early postoperative period: Is it feasible?
Kara H; Arikan AE; Dülgeroğlu O; Uras C
Indian J Cancer; 2023; 60(2):237-241. PubMed ID: 37530247
[TBL] [Abstract][Full Text] [Related]
9. The Use of Wearable Activity Monitors to Measure Upper Limb Physical Activity After Axillary Lymph Node Dissection and Sentinel Lymph Node Biopsy.
Che Bakri NA; Kwasnicki RM; Giannas E; Tenang L; Khan N; Moenig C; Imam Z; Dhillon K; Ashrafian H; Darzi A; Leff DR
Ann Surg Oncol; 2023 Nov; 30(12):7036-7045. PubMed ID: 37507555
[TBL] [Abstract][Full Text] [Related]
10. Association of Axillary Dissection With Systemic Therapy in Patients With Clinically Node-Positive Breast Cancer.
Weber WP; Matrai Z; Hayoz S; Tausch C; Henke G; Zimmermann F; Montagna G; Fitzal F; Gnant M; Ruhstaller T; Muenst S; Mueller A; Lelièvre L; Heil J; Knauer M; Egle D; Sávolt Á; Heidinger M; Kurzeder C; ; Zwahlen DR; Gruber G; Ackerknecht M; Kuemmel S; Bjelic-Radisic V; Smanykó V; Vrieling C; Satler R; Hagen D; Becciolini C; Bucher S; Simonson C; Fehr PM; Gabriel N; Maráz R; Sarlos D; Dedes KJ; Leo C; Berclaz G; Fansa H; Hager C; Reisenberger K; Singer CF; Loibl S; Winkler J; Lam GT; Fehr MK; Kohlik M; Clerc K; Ostapenko V; Maggi N; Schulz A; Andreozzi M; Goldschmidt M; Saccilotto R; Markellou P
JAMA Surg; 2023 Oct; 158(10):1013-1021. PubMed ID: 37466971
[TBL] [Abstract][Full Text] [Related]
11. Sentinel Lymph Node Biopsy vs No Axillary Surgery in Patients With Small Breast Cancer and Negative Results on Ultrasonography of Axillary Lymph Nodes: The SOUND Randomized Clinical Trial.
Gentilini OD; Botteri E; Sangalli C; Galimberti V; Porpiglia M; Agresti R; Luini A; Viale G; Cassano E; Peradze N; Toesca A; Massari G; Sacchini V; Munzone E; Leonardi MC; Cattadori F; Di Micco R; Esposito E; Sgarella A; Cattaneo S; Busani M; Dessena M; Bianchi A; Cretella E; Ripoll Orts F; Mueller M; Tinterri C; Chahuan Manzur BJ; Benedetto C; Veronesi P;
JAMA Oncol; 2023 Nov; 9(11):1557-1564. PubMed ID: 37733364
[TBL] [Abstract][Full Text] [Related]
12. Sentinel lymph node biopsy with carbon nanoparticle suspension after neoadjuvant chemotherapy for breast cancer patients.
Wei N; Hou J; Chen J; Dai M; Du K; Wang S; Ni Q
Ann R Coll Surg Engl; 2021 Nov; 103(10):752-756. PubMed ID: 34448655
[TBL] [Abstract][Full Text] [Related]
13. Accuracy of sentinel lymph node biopsy in male breast cancer: Systematic review and meta-analysis.
Parpex G; Ottaviani M; Lorphelin H; Mezzadri M; Marchand E; Cahen-Doidy L; Benifla JL; Huchon C; Mimoun C
Breast; 2024 Jun; 75():103703. PubMed ID: 38461570
[TBL] [Abstract][Full Text] [Related]
14. The Impact of Sentinel Lymph Node Biopsy on Female Patients With T3-4c Breast Cancer and 1-2 Positive Lymph Nodes: A Population-Based Cohort Study.
Yang H; Sun Y; Wang P; Qiao J; Wang C; Liu Z
Clin Breast Cancer; 2024 Apr; 24(3):e126-e137.e3. PubMed ID: 38114365
[TBL] [Abstract][Full Text] [Related]
15. Axillary ultrasound for predicting response to neoadjuvant treatment in breast cancer patients-a single institution experience.
Pislar N; Gasljevic G; Music MM; Borstnar S; Zgajnar J; Perhavec A
World J Surg Oncol; 2023 Sep; 21(1):292. PubMed ID: 37715188
[TBL] [Abstract][Full Text] [Related]
16. Patterns of completion axillary dissection for patients with cT1-2N0 breast cancer undergoing total mastectomy with positive sentinel lymph nodes.
Schwieger L; Postlewait LM; Subhedar PD; Geng F; Liu Y; Gillespie T; Arciero CA
J Surg Oncol; 2024 Mar; 129(3):468-480. PubMed ID: 37955191
[TBL] [Abstract][Full Text] [Related]
17. Omission of Axillary Dissection Following Nodal Downstaging With Neoadjuvant Chemotherapy.
Montagna G; Mrdutt MM; Sun SX; Hlavin C; Diego EJ; Wong SM; Barrio AV; van den Bruele AB; Cabioglu N; Sevilimedu V; Rosenberger LH; Hwang ES; Ingham A; Papassotiropoulos B; Nguyen-Sträuli BD; Kurzeder C; Aybar DD; Vorburger D; Matlac DM; Ostapenko E; Riedel F; Fitzal F; Meani F; Fick F; Sagasser J; Heil J; Karanlik H; Dedes KJ; Romics L; Banys-Paluchowski M; Muslumanoglu M; Perez MDRC; Díaz MC; Heidinger M; Fehr MK; Reinisch M; Tukenmez M; Maggi N; Rocco N; Ditsch N; Gentilini OD; Paulinelli RR; Zarhi SS; Kuemmel S; Bruzas S; di Lascio S; Parissenti TK; Hoskin TL; Güth U; Ovalle V; Tausch C; Kuerer HM; Caudle AS; Boileau JF; Boughey JC; Kühn T; Morrow M; Weber WP
JAMA Oncol; 2024 Apr; ():. PubMed ID: 38662396
[TBL] [Abstract][Full Text] [Related]
18. Axillary Surgery for Breast Cancer in 2024.
Heidinger M; Weber WP
Cancers (Basel); 2024 Apr; 16(9):. PubMed ID: 38730576
[TBL] [Abstract][Full Text] [Related]
19. The Feasibility and Reliability of Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Breast Cancer Patients With Negative Axillary Lymph Nodes-A Meta-analysis.
Yu M; Liu Y; Huang Z; Zhu Q; Huang Y
Breast Cancer (Auckl); 2024; 18():11782234241255856. PubMed ID: 38826850
[TBL] [Abstract][Full Text] [Related]
20. Locoregional therapy of locally advanced breast cancer: a clinical practice guideline.
Brackstone M; Fletcher GG; Dayes IS; Madarnas Y; SenGupta SK; Verma S;
Curr Oncol; 2015 Mar; 22(Suppl 1):S54-66. PubMed ID: 25848339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
